Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.
Saved in:
| Title: | Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial. |
|---|---|
| Authors: | Brown DM; Retina Consultants of Texas (Retina Consultants of America), Houston, Texas., Wykoff CC; Retina Consultants of Texas (Retina Consultants of America), Houston, Texas.; Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas., Boyer D; Retina-Vitreous Associates Medical Group, Los Angeles, California., Heier JS; Ophthalmic Consultants of Boston, Boston, Massachusetts., Clark WL; Palmetto Retina, West Columbia, South Carolina., Emanuelli A; Retina Care, Arecibo, Puerto Rico.; Emanuelli Research and Development Center, Arecibo, Puerto Rico., Higgins PM; Retina Center of New Jersey, Bloomfield., Singer M; Medical Center Ophthalmology Associates, San Antonio, Texas., Weinreich DM; Regeneron Pharmaceuticals, Tarrytown, New York., Yancopoulos GD; Regeneron Pharmaceuticals, Tarrytown, New York., Berliner AJ; Regeneron Pharmaceuticals, Tarrytown, New York., Chu K; Regeneron Pharmaceuticals, Tarrytown, New York., Reed K; Regeneron Pharmaceuticals, Tarrytown, New York., Cheng Y; Regeneron Pharmaceuticals, Tarrytown, New York., Vitti R; Regeneron Pharmaceuticals, Tarrytown, New York. |
| Source: | JAMA ophthalmology [JAMA Ophthalmol] 2021 Sep 01; Vol. 139 (9), pp. 946-955. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6173 |
|---|---|
| DOI: | 10.1001/jamaophthalmol.2021.2809 |
